Close Menu

NEW YORK – Thermo Fisher Scientific said this week that it has completed the acquisition of point-of-care molecular diagnostics company Mesa Biotech, first announced last month. The company will become part of Thermo Fisher's Life Sciences Solutions business segment and is expected to add approximately $200 million to its revenues in 2021.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.